… correlated with response to treatment with bevacizumab in … in patients with advanced
colorectal cancer receiving first-line … The highest value of arterial blood pressure recorded was …

… ) as a first-line treatment for metastatic colorectal cancer (CRC). In 2006, the FDA approved
… determine whether there was any correlation between bevacizumab-induced HTN and OS. …

… Ten studies included patients treated with bevacizumab in the first line setting, whereas four
… the correlation between bevacizumab-induced HTN and survival outcomes in patients with …

… Arterial hypertension (AHT) is a common toxicity with bevacizumab (BVZ)-containing …
Once we could not correlate the AHT, with PFS to CT/BVZ, we evaluated several cut-offs of …

… cetuximab and bevacizumab we excluded patients treated in arm B … Arterial hypertension
correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab…

… In the bevacizumab group, no statistically significant correlation was found between all
analysed SNPs and ORR. Median PFS was significantly longer inpatients with IL-8 c.-251TT …

… Bevacizumab, a humanized anti-vascular endothelial growth … the treatment of metastatic
colorectal cancer in a first-line setting, … have been tested, and arterial hypertension is one of the …

… bevacizumab (BEV) exposure in mCRC patients who were … In this study a strong correlation
was observed between the … especially in patients treated with BEV in first-line chemotherapy. …

… of bevacizumab-containing first line treatment of mCRC patients included in a clinical trial. …
on associations between patient outcome and hypertension, we next correlated available …

… not significantly increased in colorectal cancer. The general … all outcomes, except for bleeding
and arterial hypertension. … breast cancer after first‐line treatment with bevacizumab plus …